Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
36
WXXWY Quote, Financials, Valuation and Earnings
Last price:
$8.70
Seasonality move
:
5.6%
Day range:
$8.63 - $9.12
52-week range:
$4.12 - $11.21
Dividend yield:
0%
P/E ratio:
31.79x
P/S ratio:
6.57x
P/B ratio:
2.66x
Volume:
15.3K
Avg. volume:
35.3K
1-year change:
103.51%
Market cap:
$17.7B
Revenue:
$2.6B
EPS (TTM):
$0.29
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, WuXi Biologics (Cayman), Inc. has -- downside to fair value with a price target of -- per share.
WXXWY vs. S&P 500
-
Over the past 5 trading days, WuXi Biologics (Cayman), Inc. has overperformed the S&P 500 by 3.96% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
WuXi Biologics (Cayman), Inc. does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
WuXi Biologics (Cayman), Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter WuXi Biologics (Cayman), Inc. reported revenues of --.
Earnings Growth
-
WuXi Biologics (Cayman), Inc. has grown year-over-year earnings for 0 quarters straight. In the most recent quarter WuXi Biologics (Cayman), Inc. reported earnings per share of --.
Enterprise value:
14.6B
EV / Invested capital:
--
Price / LTM sales:
6.57x
EV / EBIT:
21.08x
EV / Revenue:
5.63x
PEG ratio (5yr expected):
869.68x
EV / Free cash flow:
81.74x
Price / Operating cash flow:
66.03x
Enterprise value / EBITDA:
21.08x
Gross Profit (TTM):
$1.2B
Return On Assets:
5.95%
Net Income Margin (TTM):
24.53%
Return On Equity:
7.53%
Return On Invested Capital:
7.16%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-21 | 2024-12-21 | 2024-12-21 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $3.4B | $3.1B | $2.5B | $2.7B | -- | |
| Total Assets | $6.7B | $7.1B | $7.2B | $7.7B | -- | |
| Current Liabilities | $841.7M | $1.3B | $1.1B | $936.7M | -- | |
| Total Liabilities | $1.5B | $1.8B | $1.8B | $1.6B | -- | |
| Total Equity | $5.2B | $5.3B | $5.4B | $6.1B | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-21 | 2024-12-21 | 2024-12-21 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
WXXWY
Sector
Market Cap
$17.7B
$27.9M
Price % of 52-Week High
77.61%
51.04%
Dividend Yield
0%
0%
Shareholder Yield
1.63%
-1.49%
1-Year Price Total Return
103.51%
-16.66%
Beta (5-Year)
-0.043
0.516
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$8.39
200-day SMA
Buy
Level
$7.62
Bollinger Bands (100)
Sell
Level
8 - 9.82
Chaikin Money Flow
Buy
Level
2.9K
20-day SMA
Buy
Level
$8.27
Relative Strength Index (RSI14)
Buy
Level
56.50
ADX Line
Buy
Level
8.92
Williams %R
Neutral
Level
-33.3333
50-day SMA
Buy
Level
$8.69
MACD (12, 26)
Buy
Level
1.59
25-day Aroon Oscillator
Buy
Level
76
On Balance Volume
Neutral
Level
32.3K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.847)
Buy
CA Score
(Annual)
Level (1.0527)
Buy
Beneish M-Score
(Annual)
Level (-2.7035)
Buy
Momentum Score
Level (10)
Buy
Ohlson Score
Level (-3.5612)
Buy
Piotroski F Score
(Annual)
Level (8)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Wuxi Biologics (Cayman), Inc. is an investment holding company, which provides end-to-end solutions and services for biologics discovery, development, and manufacturing services and manufacturing of biologics products. It operates through the Biologics and XDC segments. The company was founded on February 27, 2014, and is headquartered in Wuxi, China.
Stock Forecast FAQ
In the current month, WXXWY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The WXXWY average analyst price target in the past 3 months is --.
-
Where Will WuXi Biologics (Cayman), Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that WuXi Biologics (Cayman), Inc. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About WuXi Biologics (Cayman), Inc.?
Analysts are divided on their view about WuXi Biologics (Cayman), Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that WuXi Biologics (Cayman), Inc. is a Sell and believe this share price will rise from its current level to --.
-
What Is WuXi Biologics (Cayman), Inc.'s Price Target?
The price target for WuXi Biologics (Cayman), Inc. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is WXXWY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for WuXi Biologics (Cayman), Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of WXXWY?
You can purchase shares of WuXi Biologics (Cayman), Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase WuXi Biologics (Cayman), Inc. shares.
-
What Is The WuXi Biologics (Cayman), Inc. Share Price Today?
WuXi Biologics (Cayman), Inc. was last trading at $8.70 per share. This represents the most recent stock quote for WuXi Biologics (Cayman), Inc.. Yesterday, WuXi Biologics (Cayman), Inc. closed at $8.70 per share.
-
How To Buy WuXi Biologics (Cayman), Inc. Stock Online?
In order to purchase WuXi Biologics (Cayman), Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get WXXWY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
WXXWY
Sector
P/E ratio
31.79x
23.85x
PEG ratio
869.68x
-0.01x
P/B ratio
2.66x
1.81x
Price / LTM sales
6.57x
1.58x
Growth Metrics
WXXWY
Sector
Revenue growth
--
4.62%
Earnings growth
--
10.5%
Revenue (5-year growth)
35.1%
6.5%
Earnings forecast
--
-$0.21
Profitability
WXXWY
Sector
Profitability FY 2024
$1.1B
$3.6M
Return on invested capital
7.16%
-31.87%
Return on assets
5.95%
-28.18%
Return on equity
7.53%
-37.63%
Earnings Date
Last Earnings Date
Aug
19
Next Earnings Date
Mar
24
Estimated Next Earnings Date
Nov
18
Balance Sheet
WXXWY
Sector
Total cash
$1.5B
$26.4M
Short term investments
$333M
$25.7M
Total assets
$7.8B
$76.9M
Long term debt
--
$3.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 20
Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.
Buy
54
BMRN alert for Dec 20
BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.
Buy
82
RKLB alert for Dec 20
Rocket Lab Corp. [RKLB] is up 17.72% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
